EUVIMEDEUVIMED entdecken
Crossref

Antifungal susceptibility profiles of Cryptococcus neoformans strains clinically isolated from non-HIV-infected patients in Nagasaki, Japan

Nobuyuki Ashizawa iD, Takahiro Takazono iD, Yuya Ito, Nana Nakada, Tatsuro Hirayama, Kazuaki Takeda, Shotaro Ide, Naoki Iwanaga, Masato Tashiro, Naoki Hosogaya, Katsunori Yanagihara, Hiroshi Mukae und 1 weitere

Medical Mycology · 2023

DOI: 10.1093/mmy/myad100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Mycology, 2023. Verfasst von Nobuyuki Ashizawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Infection Control and Education Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852- 8501, Japan. Hauptthemen laut MEDLINE: Antifungal Agents, Cryptococcus neoformans, Cryptococcosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Data on antifungal susceptibility of Cryptococcus neoformans are limited in Japan. A total of 89 C. neoformans strains isolated from 83 non-human immunodeficiency virus-infected patients with cryptococcosis between 1997 and 2021 in Nagasaki, Japan, were investigated. Using the reference method M27-Ed4 by the Clinical and Laboratory Standards Institute, the minimum inhibitory concentration for 90% of isolates of fluconazole, itraconazole, voriconazole, amphotericin B, and flucytosine were 4, 0.125, 0.06, 0.5, and 4 µg/ml, respectively, which were below the reported epidemiological cutoff values, without any detectable non-wild-type strains. Our findings imply no increasing trend of antifungal-resistant C. neoformans in Nagasaki, Japan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCryptococcus neoformansCryptococcosisHumansJapanMicrobial Sensitivity TestsDrug Resistance, FungalMaleAdultMiddle AgedFemaleFluconazoleAmphotericin BAged

Stichwörter der Autor:innen

Cryptococcus neoformansJapanantifungal drugsepidemiological cutoff valuesminimum inhibitory concentrations

Substanzen

Antifungal AgentsFluconazoleAmphotericin B

Autor:innen und Institutionen

  • Infection Control and Education Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852- 8501, Japan.
  • Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
  • Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
  • Health Center, Nagasaki University, 1-14 Bunkyo, Nagasaki 852-8521, Japan.
  • Department of Pharmacotherapeutics, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
  • Infectious Diseases Experts Training Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.

ORCID-Profile: Nobuyuki Ashizawa, Takahiro Takazono

Zitieren

APA

Ashizawa, N., Takazono, T., Ito, Y., Nakada, N., Hirayama, T., Takeda, K., Ide, S., Iwanaga, N., Tashiro, M., Hosogaya, N., Yanagihara, K., Mukae, H., & Izumikawa, K. (2023). Antifungal susceptibility profiles of Cryptococcus neoformans strains clinically isolated from non-HIV-infected patients in Nagasaki, Japan. Medical Mycology. https://doi.org/10.1093/mmy/myad100

Vancouver

Ashizawa N, Takazono T, Ito Y, Nakada N, Hirayama T, Takeda K, et al. Antifungal susceptibility profiles of Cryptococcus neoformans strains clinically isolated from non-HIV-infected patients in Nagasaki, Japan. Medical Mycology. 2023. doi:10.1093/mmy/myad100

BibTeX
@article{Ashizawa2023,
  author = {Ashizawa, Nobuyuki and Takazono, Takahiro and Ito, Yuya and Nakada, Nana and Hirayama, Tatsuro and Takeda, Kazuaki and Ide, Shotaro and Iwanaga, Naoki and Tashiro, Masato and Hosogaya, Naoki and Yanagihara, Katsunori and Mukae, Hiroshi and Izumikawa, Koichi},
  title = {Antifungal susceptibility profiles of Cryptococcus neoformans strains clinically isolated from non-HIV-infected patients in Nagasaki, Japan},
  journal = {Medical Mycology},
  year = {2023},
  doi = {10.1093/mmy/myad100}
}
Kostenlos starten →